Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Umbricht

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Analytical Toxicology|October 24, 2000
Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testingM A Huestis, E J Cone, C J Wong, et al.
Drug and Alcohol Dependence|April 27, 1999
Improvement in naltrexone treatment compliance with contingency managementK L Preston, K Silverman, A Umbricht, et al.
Molecular Pharmaceutics|October 31, 2018
Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for <sup>64</sup>Cu-Based PET ImagingChristoph A Umbricht, Martina Benešová, Roger Hasler, et al.
The Prostate|April 11, 2018
Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cellsBenedikt Kranzbühler, Souzan Salemi, Christoph A Umbricht, et al.
Behavioural Pharmacology|April 21, 2004
Cyclazocine: comparison to hydromorphone and interaction with cocaineK L Preston, A Umbricht, J R Schroeder, et al.
Journal of Consulting and Clinical Psychology|November 6, 1998
Broad beneficial effects of cocaine abstinence reinforcement among methadone patientsK Silverman, C J Wong, A Umbricht-Schneiter, et al.
Drug and Alcohol Dependence|October 21, 1999
Naltrexone shortened opioid detoxification with buprenorphineA Umbricht, I D Montoya, D R Hoover, et al.
Journal of Analytical Toxicology|September 17, 1999
Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testingK L Preston, M A Huestis, C J Wong, et al.
Theranostics|February 12, 2020
Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entityLuisa M Deberle, Martina Benešová, Christoph A Umbricht, et al.
EJNMMI Research|January 20, 2017
<sup>44</sup>Sc-PSMA-617 for radiotheragnostics in tandem with <sup>177</sup>Lu-PSMA-617-preclinical investigations in comparison with <sup>68</sup>Ga-PSMA-11 and <sup>68</sup>Ga-PSMA-617Christoph A Umbricht, Martina Benešová, Raffaella M Schmid, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Analytical Toxicology|October 24, 2000
Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testingM A Huestis, E J Cone, C J Wong, et al.
Drug and Alcohol Dependence|April 27, 1999
Improvement in naltrexone treatment compliance with contingency managementK L Preston, K Silverman, A Umbricht, et al.
Molecular Pharmaceutics|October 31, 2018
Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for <sup>64</sup>Cu-Based PET ImagingChristoph A Umbricht, Martina Benešová, Roger Hasler, et al.
The Prostate|April 11, 2018
Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cellsBenedikt Kranzbühler, Souzan Salemi, Christoph A Umbricht, et al.
Behavioural Pharmacology|April 21, 2004
Cyclazocine: comparison to hydromorphone and interaction with cocaineK L Preston, A Umbricht, J R Schroeder, et al.
Journal of Consulting and Clinical Psychology|November 6, 1998
Broad beneficial effects of cocaine abstinence reinforcement among methadone patientsK Silverman, C J Wong, A Umbricht-Schneiter, et al.
Drug and Alcohol Dependence|October 21, 1999
Naltrexone shortened opioid detoxification with buprenorphineA Umbricht, I D Montoya, D R Hoover, et al.
Journal of Analytical Toxicology|September 17, 1999
Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testingK L Preston, M A Huestis, C J Wong, et al.
Theranostics|February 12, 2020
Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entityLuisa M Deberle, Martina Benešová, Christoph A Umbricht, et al.
EJNMMI Research|January 20, 2017
<sup>44</sup>Sc-PSMA-617 for radiotheragnostics in tandem with <sup>177</sup>Lu-PSMA-617-preclinical investigations in comparison with <sup>68</sup>Ga-PSMA-11 and <sup>68</sup>Ga-PSMA-617Christoph A Umbricht, Martina Benešová, Raffaella M Schmid, et al.
Pageof 3